Cargando…
Use of the Chinchilla Model to Evaluate the Vaccinogenic Potential of the Moraxella catarrhalis Filamentous Hemagglutinin-like Proteins MhaB1 and MhaB2
Moraxella catarrhalis causes significant health problems, including 15–20% of otitis media cases in children and ∼10% of respiratory infections in adults with chronic obstructive pulmonary disease. The lack of an efficacious vaccine, the rapid emergence of antibiotic resistance in clinical isolates,...
Autores principales: | Shaffer, Teresa L., Balder, Rachel, Buskirk, Sean W., Hogan, Robert J., Lafontaine, Eric R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699455/ https://www.ncbi.nlm.nih.gov/pubmed/23844117 http://dx.doi.org/10.1371/journal.pone.0067881 |
Ejemplares similares
-
Response to the white paper on MHA reform: marginalisation of patients detained under part III of the MHA
por: Markham, Sarah
Publicado: (2021) -
Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2
por: Balder, Rachel, et al.
Publicado: (2013) -
MHA Herbarium: Eastern European collections of vascular plants
por: Seregin, Alexey P., et al.
Publicado: (2020) -
Compulsory treatment of physical illness under MHA 1983
por: Wheeler, Robert, et al.
Publicado: (2022) -
Section 12(2) MHA approval process is fit for purpose
por: Khwaja, Masum
Publicado: (2020)